Gastric Cancer
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. Apr 7, 2008; 14(13): 1990-1996
Published online Apr 7, 2008. doi: 10.3748/wjg.14.1990
Table 3 Relationship between the expressions of syndecan-1, E-cadherin and integrin β3 and the prognosis of gastric carcinoma patients
GroupsnMean survival time (mo)5-yr survival rate (%)χ2P
Syndecan-1 expression
Low expression6832.10 ± 4.1612.8053.130
High expression50123.80 ± 5.5691.66
E-cadherin expression
Low expression6833.69 ± 4.3312.8043.360
High expression50119.78 ± 5.8793.59
Integrin β3 expression
Low expression59103.30 ± 7.7372.7535.110
High expression5933.12 ± 4.6413.85